🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Breast cancer patients scheduled to receive myelosuppressive chemotherapy (...
Status
Completed
Location
Vietnam National Cancer Institute (Hospital K)
Start Date
2016-05-25
Trial ID
NCT03376503
Treatments Being Tested
Drugs used in chemotherapy use different ways to stop tumor cells from divi...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2005-01
Trial ID
NCT00031629
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Status
Terminated
Location
Tennessee Valley Gynecologic Oncology
Start Date
2012-06-04
Trial ID
NCT01533207
This study will compare the pharmacokinetics and pharmacodynamics, after si...
Status
Completed
Location
Marcos Giusti
Start Date
2022-03-18
Trial ID
NCT04873765
Treatments Being Tested
This is a Phase III, randomised, assessor-blind, parallel group, multicentr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-01
Trial ID
NCT02768714
Treatments Being Tested
This phase II trial tests how well etoposide, prednisone, vincristine, cycl...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-05-08
Trial ID
NCT06738368
This is a randomized, multicentre, Phase 3 study. Patients will be randomly...
Status
Unknown
Location
COIBA
Start Date
2015-08
Trial ID
NCT03404752
Treatments Being Tested
This phase I trial studies the side effects and best dose of tivantinib and...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-07-24
Trial ID
NCT01654965
This phase I trial tests the safety, side effects and best dose of ruxoliti...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-12-16
Trial ID
NCT07278856
Treatments Being Tested